Cytogenetics market to be valued at $5.5b by 2031

Its growth is attributed to the rising prevalence of genetic disorders and cancer.

The cytogenetics market is projected to reach $5.5b by 2031 at a compound annual growth rate of 9.6%, said Meticulous Market Research Pvt. Ltd.

The sector’s expansion is attributed to the increasing prevalence of genetic disorders and cancer, along with increased adoption of molecular cytogenetic techniques.

In addition, developments in next-generation sequencing, fluorescence in situ hybridisation, and chromosomal microarray analysis have improved the speed and accuracy of detecting chromosomal abnormalities.

Meanwhile, the demand for personalised medicine, increasing government initiatives, and funding for genetic research are key drivers for market growth.